Recent

% | $
Quotes you view appear here for quick access.

Direxion Daily Financial Bear 3X ETF Message Board

mr_frederick_yugo 8 posts  |  Last Activity: Apr 30, 2015 8:19 AM Member since: Aug 11, 2008
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • mr_frederick_yugo by mr_frederick_yugo Apr 30, 2015 8:19 AM Flag

    Guess the sale of equity in Incuron is the last ditch effort. It's Entolimod or bust. FDA EUA or bust. Cleveland knows they're going to get slaughtered on the equity raise to increase stockholders equity from a pathetic $1.8m to the paltry requirement of $2/5m. They knew that they were quickly running out of $$$ to pay for mgt's lifestyles. The sale of an balance sheet asset will drive the equity raise price down even further.

    Without the (will not come) miracle of a EUA, this stock will be $2.25 - 2.50 at very best within months. Probably much lower. What outfit will get involved with these clowns based on their operating history? At lease w/out some of the most onerous terms known to mankind?

  • Reply to

    PR

    by okeefeenokeedowns Apr 27, 2015 9:24 AM
    mr_frederick_yugo mr_frederick_yugo Apr 27, 2015 2:32 PM Flag

    Great market/price reaction. All I can say is: lol

  • Reply to

    China Warns North Korean Nuclear Threat Is Rising

    by voof7 Apr 23, 2015 8:52 AM
    mr_frederick_yugo mr_frederick_yugo Apr 23, 2015 11:49 AM Flag

    LOL. So fund and purchase product from a Russian-run company in response..............Don't you get it yet?

  • lolololololLOLOLOLOLOLOL-

    I wonder what it would mean to CBLI if the poster presentation was NOT accepted for this event that CBLI seemingly goes to every year. Also - would they have issued a PR announcing that ASCO had rejected the Study Results poster presentation? Again, too too much lol.

  • Reply to

    Volume

    by remainscalm Mar 16, 2015 10:15 AM
    mr_frederick_yugo mr_frederick_yugo Mar 16, 2015 10:56 AM Flag

    Just a 7:30am news release bragging about the completion of a phase 1 trial in the Russian Federation which will take forever to result in anything. You'll probably see the price go down accordingly when it is realized that it's only vapor.

  • mr_frederick_yugo by mr_frederick_yugo Mar 14, 2015 11:15 AM Flag

    CBLI's pitiful shareholder equity does not meet Nasdaq's minimum requirements. lol

  • mr_frederick_yugo by mr_frederick_yugo Mar 3, 2015 9:29 AM Flag

    So CBLI/Incuron was awarded a patent for the composition of matter for CBLI 0137. It provides protection through 2030.
    Does anyone think CBLI will be in existence in 2030?

  • Reply to

    dod contract

    by practiceliving Feb 18, 2015 8:49 AM
    mr_frederick_yugo mr_frederick_yugo Feb 18, 2015 5:29 PM Flag

    snowboard - I did some checking to refresh my memory on Barda's purchase of Neupogen from Amgen. Ths occurred just before Amgen's patent on Neutrogen was to expire on 12/31/13, opening up competition from generics.
    If the FDA and DOD think along the same philosophical lines as Barda, CBLI is in big trouble. Barda (and I believe) the FDA are big on re-purposing existing drugs. IMO that is the laziest route and totally pathetic. They figure large companies like Amgen will be able to meet volume and storage requirements simply due to their massive size. Think about it. Barda/FDA are charged with overseeing and funding an ARS drug. So instead of furthering the ability of smaller companies who are working solely (or primarily) on ARS, they choose to RE-PURPOSE an existing drug created for another reason. A blockbuster expiring patent drug involving a big player (Amgen) who is about to face generic competition.
    This kinda #$%$ just symbolizes how gov't agencies perceive their mission and go about (accomplishing) it. The route requiring the least effort by utilizing and funding the entrenched.

    BTW, the tool head of Barda was on 60 Minutes last Sunday. I only caught the last part but the segment was done as Barda is halfway through the time frame to accomplish its mission . The interviewer went down a list of things and areas asking the guy about the agency's progress. To summarize his responses = they haven't gotten anywhere on anything. The douche was exposed as a total nothing.

FAZ
11.78-0.3100(-2.56%)May 4 4:00 PMEDT